NYSE:IQV (USA) Also trade in: Germany UK

IQVIA Holdings Inc

$ 158.4 1.04 (0.66%)
Volume: 581,533 Avg Vol (1m): 1,364,642
Market Cap $: 31.23 Bil Enterprise Value $: 41.77 Bil
P/E (TTM): 130.78 P/B: 4.84
Earnings Power Value 118.08
Net Current Asset Value -61.95
Tangible Book -54.8
Projected FCF 57.5
Median P/S Value 82.01
Graham Number 0
Peter Lynch Value 15.67
DCF (FCF Based) 0
DCF (Earnings Based) 0
1Y (-%)

Financial Strength : 4.6/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.09
Cash-To-Debt range over the past 10 years
Min: 0.08, Med: 0.29, Max: 0.51
Current: 0.09
0.08
0.51
Equity-to-Asset 0.29
Equity-to-Asset range over the past 10 years
Min: -0.55, Med: -0.11, Max: 0.41
Current: 0.29
-0.55
0.41
Debt-to-Equity 1.71
Debt-to-Equity range over the past 10 years
Min: -7.77, Med: -2.56, Max: 1.71
Current: 1.71
-7.77
1.71
Debt-to-EBITDA 5.84
Debt-to-EBITDA range over the past 10 years
Min: 3.16, Med: 4.98, Max: 8.48
Current: 5.84
3.16
8.48
Interest Coverage 1.92
Interest Coverage range over the past 10 years
Min: 1.92, Med: 3.48, Max: 6.71
Current: 1.92
1.92
6.71
Piotroski F-Score 4
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.80
DISTRESS
GREY
SAFE
Beneish M-Score -2.71
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 3.65%
WACC 9.53%

Profitability & Growth : 6/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 7.80
Operating Margin range over the past 10 years
Min: 7.77, Med: 9.34, Max: 11.82
Current: 7.8
7.77
11.82
Net Margin % 2.35
Net Margin range over the past 10 years
Min: 1.06, Med: 4.44, Max: 13.16
Current: 2.35
1.06
13.16
ROE % 3.43
ROE range over the past 10 years
Min: 1.78, Med: 3.52, Max: 15.36
Current: 3.43
1.78
15.36
ROA % 1.09
ROA range over the past 10 years
Min: 0.57, Med: 7.75, Max: 20.82
Current: 1.09
0.57
20.82
ROC (Joel Greenblatt) % 182.67
ROC (Joel Greenblatt) range over the past 10 years
Min: 151.3, Med: 219.28, Max: 338.36
Current: 182.67
151.3
338.36
3-Year Total Revenue Growth Rate 22.00
3-Year Revenue Growth Rate range over the past 10 years
Min: 1.5, Med: 5.3, Max: 9
Current: 3.1
1.5
9
3-Year Total EBITDA Growth Rate 34.80
3-Year EBITDA Growth Rate range over the past 10 years
Min: 5.8, Med: 12.15, Max: 22.2
Current: 13.9
5.8
22.2
3-Year EPS w/o NRI Growth Rate -26.20
N/A

» IQV's 30-Y Financials

Financials (Next Earnings Date: 2019-07-24)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NYSE:IQV

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Medical Diagnostics & Research » Medical Diagnostics & Research    NAICS : 621399    SIC : 8099
Compare NYSE:A XSWX:LONN NAS:IDXX NYSE:MTD XAMS:PHIA SHSE:603259 NYSE:LH NYSE:WAT NYSE:DGX NAS:EXAS XTER:SRT3 TSE:6869 NAS:DXCM NYSE:PKI NAS:ILMN XPAR:BIM NYSE:BIO NYSE:QGEN XPAR:ERF NAS:ICLR
Traded in other countries QTS.Germany 0JDM.UK
Address 83 Wooster Heights Road, Danbury, CT, USA, 06810
IQVIA was created from the merger of the healthcare data and analytics of IMS Health with the global contract research organization powerhouse of Quintiles. The CRO segment focuses primarily on providing outsourced phase 2-4 clinical trials for pharmaceutical, device, and diagnostic companies. The legacy IMS business provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers.

Ratios

Current vs industry vs history
PE Ratio (TTM) 130.78
PE Ratio range over the past 10 years
Min: 15.67, Med: 24.5, Max: 291.95
Current: 130.78
15.67
291.95
Forward PE Ratio 25.19
N/A
PE Ratio without NRI 130.78
PE without NRI range over the past 10 years
Min: 15.67, Med: 24.5, Max: 291.95
Current: 130.78
15.67
291.95
Price-to-Owner-Earnings 40.19
Price-to-Owner-Earnings range over the past 10 years
Min: 14.92, Med: 27.88, Max: 40.86
Current: 40.19
14.92
40.86
PB Ratio 4.84
PB Ratio range over the past 10 years
Min: 2.02, Med: 2.84, Max: 4.91
Current: 4.84
2.02
4.91
PS Ratio 3.10
PS Ratio range over the past 10 years
Min: 1.07, Med: 1.6, Max: 3.14
Current: 3.1
1.07
3.14
Price-to-Free-Cash-Flow 48.61
Price-to-Free-Cash-Flow range over the past 10 years
Min: 14.11, Med: 23.7, Max: 49.42
Current: 48.61
14.11
49.42
Price-to-Operating-Cash-Flow 27.53
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 12.19, Med: 18.15, Max: 27.99
Current: 27.53
12.19
27.99
EV-to-EBIT 53.54
EV-to-EBIT range over the past 10 years
Min: 13.7, Med: 17.8, Max: 56.6
Current: 53.54
13.7
56.6
EV-to-EBITDA 21.60
EV-to-EBITDA range over the past 10 years
Min: 11.5, Med: 14.5, Max: 29.3
Current: 21.6
11.5
29.3
EV-to-Revenue 3.97
EV-to-Revenue range over the past 10 years
Min: 1.3, Med: 1.9, Max: 4.1
Current: 3.97
1.3
4.1
PEG Ratio 9.62
PEG Ratio range over the past 10 years
Min: 1.19, Med: 5.86, Max: 19.89
Current: 9.62
1.19
19.89
Current Ratio 1.14
Current Ratio range over the past 10 years
Min: 1.09, Med: 1.29, Max: 1.65
Current: 1.14
1.09
1.65
Quick Ratio 1.14
Quick Ratio range over the past 10 years
Min: 1.09, Med: 1.29, Max: 1.65
Current: 1.14
1.09
1.65
Days Sales Outstanding 41.20
Days Sales Outstanding range over the past 10 years
Min: 25, Med: 32.37, Max: 52.7
Current: 41.2
25
52.7
Days Payable 113.20
Days Payable range over the past 10 years
Min: 8.02, Med: 11.45, Max: 113.2
Current: 113.2
8.02
113.2

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -18.30
3-Year Share Buyback Rate range over the past 10 years
Min: -22, Med: -9.4, Max: 2.5
Current: -18.3
-22
2.5

Valuation & Return

Current vs industry vs history
Price-to-Projected-FCF 2.75
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 1.77, Med: 2.08, Max: 2.76
Current: 2.75
1.77
2.76
Price-to-Median-PS-Value 1.93
Price-to-Median-PS-Value range over the past 10 years
Min: 0.68, Med: 1, Max: 1.93
Current: 1.93
0.68
1.93
Price-to-Peter-Lynch-Fair-Value 10.10
Price-to-Peter-Lynch-Fair-Value range over the past 10 years
Min: 1.21, Med: 3.81, Max: 17.49
Current: 10.1
1.21
17.49
Earnings Yield (Joel Greenblatt) % 1.87
Earnings Yield (Greenblatt) range over the past 10 years
Min: 1.8, Med: 5.6, Max: 7.3
Current: 1.87
1.8
7.3
Forward Rate of Return (Yacktman) % 14.96
Forward Rate of Return range over the past 10 years
Min: 14.9, Med: 16.2, Max: 22.3
Current: 14.96
14.9
22.3

More Statistics

Revenue (TTM) (Mil) $ 10,533
EPS (TTM) $ 1.21
Beta 1.2
Volatility % 31.69
52-Week Range $ 104.75 - 164.13
Shares Outstanding (Mil) 197.5

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 4
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy N
Higher Current Ratio yoy N
Less Shares Outstanding yoy Y
Higher Gross Margin yoy N
Higher Asset Turnover yoy N